Universal Health (UHS) Stock Price & Analysis
UHS Stock Chart & Stats
- Day’s Range
- MXN 2,539.00 - MXN 2,539.00
- 52-Week Range
- MXN 2,500.00 - MXN 4,380.00
- Previous Close
- MXN 2,539.00
- Volume
- 0
- Average Volume (3M)
- 0
- Market Cap
- MXN 194.88B
- Enterprise Value
- MXN 16.46B
- Total Cash (Recent Filing)
- MXN 168.75M
- Total Debt (Recent Filing)
- MXN 6.18B
- Price to Earnings (P/E)
- 7.3
- Beta
- 0.22
- Next Earnings
- Mar 03, 2027 (Est.)
- EPS Estimate
- 106.06
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 0.54%
Bulls Say, Bears Say
Bulls Say
Broad Patient Volume Growth
Broad-based admissions and emergency department growth indicates durable demand across UHS facilities rather than dependence on one service line. Higher utilization supports revenue absorption of fixed costs, strengthens operating leverage, and provides a foundation for continued growth as recently added capacity ramps.
Durable Profitability
UHS combines multi-year revenue expansion with healthy operating, EBITDA, and net margins, demonstrating an established earnings base. Although margins are slightly below 2025 levels, the continued profitability should support internal investment, debt service, and resilience through normal reimbursement or cost fluctuations.
Behavioral Health Platform Expansion
Talkspace adds a nationwide virtual platform to UHS's facility network, creating opportunities to connect lower-acuity patients with higher-acuity services and expand outpatient access. This integrated continuum can improve referrals, care coordination, and revenue opportunities as the platform scales over the next several quarters.
Bears Say
Medicaid Reimbursement Headwind
The expected loss of Medicaid supplemental payments represents a material structural pressure on future earnings, particularly across states and facilities that benefited from prior programs. The magnitude could reduce margin and cash generation, forcing greater reliance on volume, pricing, and efficiency initiatives to offset reimbursement changes.
Underperforming Facility Ramps
Delayed hospital ramps and Laurel Ridge's continuing losses are suppressing near-term earnings while UHS carries the costs of facilities that have not reached intended productivity. Recovery depends on operational progress, physician development, and recertification, leaving execution risk across multiple sites over the next several quarters.
Higher Leverage
Rising leverage reduces financial flexibility even though the balance sheet remains generally sound. More debt increases exposure to refinancing and interest-cost pressure, while limiting the capacity to absorb weaker operating results or fund expansion without placing additional demands on future cash generation and capital allocation.
UHS FAQ
What was Universal Health’s price range in the past 12 months?
What is Universal Health’s market cap?
When is Universal Health’s upcoming earnings report date?
How were Universal Health’s earnings last quarter?
Is Universal Health overvalued?
Does Universal Health pay dividends?
What is Universal Health’s EPS estimate?
How many shares outstanding does Universal Health have?
What happened to Universal Health’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Universal Health?
What is the TipRanks Smart Score and how is it calculated?
Universal Health Stock Smart Score
Company Description
Universal Health
Universal Health Services, Inc. (UHS), operating through its various divisions, is a healthcare entity that both owns and manages a network of acute care hospitals, along with outpatient and specialized behavioral health treatment centers. Its business operations are strategically bifurcated into two main segments: Acute Care Hospital Services and Behavioral Health Care Services. The hospitals under its management provide a comprehensive spectrum of medical provisions, encompassing general and specialty surgical interventions, internal medicine, obstetrics, urgent and emergency department services, diagnostic imaging (radiology), cancer therapy (oncology), advanced diagnostic procedures, cardiac care, pediatric medicine, pharmaceutical services, and mental health support. As of a reported date of February 24, 2022, the company's significant presence included the ownership or operation of 363 inpatient facilities, complemented by 40 outpatient and other specialized sites. These facilities are distributed across 39 U.S. states, the District of Columbia, the United Kingdom, and Puerto Rico. Beyond direct patient care, UHS also extends into commercial health insurance provision and offers a variety of crucial management support functions. These include centralized procurement, information technology infrastructure, financial oversight and control mechanisms, strategic facilities planning, physician talent acquisition, administrative staff management, marketing initiatives, and public relations efforts. Universal Health Services, Inc. was established in 1978 and maintains its principal executive offices in King of Prussia, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Marc D. Miller
- Employees
- 101,500
- Website
- uhs.com
- Address
- Universal Corporate Center, King of Prussia, PA, 19406-0958, US
Universal Health (UHS) Earnings & Revenues
UHS Earnings Call
Earnings Call SentimentNeutral
The call reflected a mixed but cautiously constructive outlook. UHS reported solid acute care admissions, emergency department visits, behavioral health volumes, cash flow, labor trends, and strategic progress in outpatient access and Talkspace integration. However, these positives were offset by lower adjusted EPS and EBITDA, slower de novo hospital ramps, a decline in surgical volumes, Laurel Ridge losses, exchange-related pressure, and substantial expected Medicaid supplemental payment headwinds. Management reiterated guidance but expects 2026 results toward the lower end of the ranges, making the overall tone balanced.
View all MX:UHS earnings summariesUHS Net sales Breakdown
- 9.61% Medicare
- 10.85% Managed Medicare
- 12.97% Medicaid
- 13.27% Managed Medicaid
- 25.89% Managed Care (HMO and PPOs)
- 5.07% UK Revenue
- 6.41% Other patient revenue and adjustments, net
- 7.08% Other non-patient revenue
UHS Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 0 | 13 |
| Technical Analysis | 3 | 0 | 2 |
| Moving Averages | 1 | 0 | 11 |